Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: Action LADA 6

التفاصيل البيبلوغرافية
العنوان: Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: Action LADA 6
المؤلفون: Marie-Christine Simon, Barbara Menart, Michael Roden, Hubert Kolb, R. David G. Leslie, Paolo Pozzilli, M. N. Pham, Alexander Strom, Nanette C. Schloot
المصدر: Cytokine. 58:148-151
بيانات النشر: Elsevier BV, 2012.
سنة النشر: 2012
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Chemokine, medicine.medical_treatment, Immunology, Enzyme-Linked Immunosorbent Assay, Type 2 diabetes, Biochemistry, Interferon-gamma, Internal medicine, Diabetes mellitus, Humans, Immunology and Allergy, Medicine, Age of Onset, Molecular Biology, Aged, Type 1 diabetes, biology, business.industry, Case-control study, Toxoid, Hematology, Middle Aged, medicine.disease, Diabetes Mellitus, Type 1, Cytokine, Endocrinology, Diabetes Mellitus, Type 2, Case-Control Studies, Interleukin 13, biology.protein, Interleukin-2, Female, business
الوصف: Type 1 diabetes and latent autoimmune diabetes in adults (LADA) are thought to result from immune-mediated β-cell destruction. It remains unclear why LADA is clinically less severe compared to type 1 diabetes. This study aimed to compare the pro-inflammatory (interferon-γ, IFN-γ) and anti-inflammatory (interleukin-13, IL-13) T-cell responses in humans with LADA and type 1 diabetes.IFN-γ and IL-13 T-cell responses to a panel of 16 (auto)-antigens were tested using an enzyme linked immune-spot technique and peripheral T-cells from 35 patients with type 1 diabetes, 59 patients with type 2 diabetes, 23 LADA patients, and 42 control subjects.LADA and type 1 diabetes patients did not display any statistically significant differences in the frequency of IFN-γ or IL-13 responses to auto-antigenic stimuli, positive control or mitogen. Overall very low T cell reactivity to autoantigens was detected in all groups. IL-13 responses but not IFN-γ responses to recall antigen tetanus toxoid were higher in healthy control subjects compared to patients with type 1 or type 2 diabetes or LADA (P0.05). Diabetes, independent of type, was associated with weaker response to recall antigen tetanus toxoid.LADA patients are indistinguishable from type 1 diabetes patients for cellular IFN-γ and IL-13 responses upon mitogen and recall antigen stimulation. These results extend previous findings showing that systemic cytokine/chemokine and humoral responses in type 1 diabetes and LADA are similar.
تدمد: 1043-4666
DOI: 10.1016/j.cyto.2012.01.002
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47fd2017acff2776add0d2199df55007
https://doi.org/10.1016/j.cyto.2012.01.002
Rights: CLOSED
رقم الانضمام: edsair.doi.dedup.....47fd2017acff2776add0d2199df55007
قاعدة البيانات: OpenAIRE
الوصف
تدمد:10434666
DOI:10.1016/j.cyto.2012.01.002